Webinar: RWE Reality Check: Routine Patient Health Records and Regulatory Requirements by InsideScientific

RWE Reality Check: Routine Patient Health Records and Regulatory Requirements

About

Real-world evidence (RWE) is revolutionizing healthcare, but harnessing the power of routine patient health records for regulatory-compliant RWE studies presents unique challenges.

This webinar will explore the key differences between clinical trial data and real-world data, and how to bridge this gap to ensure robust and reliable RWE that meets the threshold of regulatory grade.

Key Topics:

Understand the inherent differences between clinical trial and real-world data collection methodologies

Address selection bias and ensure the inclusion of the right patients for your RWE study

Evaluate the similarity of real-world data to clinical trial data, and the role of analytics in ensuring data quality and reliability of study results

Review best practices for these RWE challenges to ensure that your data meets regulatory requirements

Presenters

Andy Klink, PhD, MPH

Senior Director, Business Development, Real-World Evidence and Insights, Cardinal Health

Andy Klink has over 15 years of experience in academia and industry with health economics and outcomes research, multi-level mixed-effects analysis, longitudinal analysis, comparative effectiveness, and patient-oriented research.

Harlen Hays, MPH

Director, Research Analytics, Real-World Evidence and Insights, Cardinal Health

Harlen D. Hays, MPH leads a team of senior statisticians and data scientists in the conduct of statistical analysis and database management of real-world data from medical chart reviews, administrative claims databases, electronic medical record databases, and other sources for biopharmaceutical companies seeking to generate real-world evidence.

Bruce A. Feinberg, DO

Chief Medical Officer, Real-World Evidence and Insights, Cardinal Health

Bruce Feinberg, DO is nationally recognized for his expertise in specialty oncology and the business of specialty healthcare. Dr. Feinberg has been instrumental in the development of clinical pathways that aim to control costs, improve quality, and increase predictability.

Liz Mearns, PharmD

Director of Business Development, Real-World Data and Evidence, Cardinal Health

Liz Mearns, PharmD currently serves as a Director of Business Development, Real-World Data and Evidence at Cardinal Health. Prior to joining Cardinal Health, Liz was a health economist with over 12 years of experience in academia, industry, and global consulting. She has demonstrated excellence in providing strategic guidance, robust RWE development and cross-functional collaboration.

First Name*

Last Name*

Email Address*

Country / Region*

Job Title*

Organization / Company*

Organization Type*

Current Therapeutic Area of Focus

Oncology

Rheumatology

Gastroenterology

Urology

Neurology

Nephrology

Dermatology

Immunology

Ophthalmology

Other

Not Applicable